ロード中...
Lisdexamfetamine in the treatment of moderate-to-severe binge eating disorder in adults: systematic review and exploratory meta-analysis of publicly available placebo-controlled, randomized clinical trials
BACKGROUND: Preliminary placebo-controlled evidence paved the ground to the US Food and Drug Administration approval extension of lisdexamfetamine for the treatment of moderate-to-severe binge eating disorder (BED) in adults. OBJECTIVES: To provide a preliminary qualitative and quantitative synthesi...
保存先:
| 出版年: | Neuropsychiatr Dis Treat |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4966690/ https://ncbi.nlm.nih.gov/pubmed/27524900 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S109637 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|